Application of metabolomics on diagnosis and treatment of patients with psoriasis in traditional Chinese medicine

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1844, Issue 1 PART B, 2014, Pages 280-288

  Lu, Chuanjian ^a   Deng, Jingwen ^a   Li, Li ^a   Wang, Dongmei ^a   Li, Guozheng ^b  

^a GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Latent Structures Discriminant Analysis; Metabolomics; Psoriasis; Syndrome differentiation; Traditional Chinese medicine

Indexed keywords

11 HYDROXYEICOSATETRAENOATE GLYCERYL ESTER; 12A HYDROXY 3 OXOCHOLADIENIC ACID; 20 CARBOXYLEUKOTRIENE B4; 4 HYDROXYBUTYRIC ACID; 5,6 DIHYDROXYPROSTAGLANDIN F1A; 7 ALPHA HYDROXY 3 OXO 4 CHOLESTENOATE; ANDROSTERONE SULFATE; ARACHIDONIC ACID; ARGININE; BETA3 INTEGRIN; CHINESE DRUG; CYTOSOLIC PHOSPHOLIPASE A2; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FC RECEPTOR IIA; GELATINASE B; GLUCOSAMINE 6 SULFATE; INOSINE PHOSPHATE; J2 2 GLYCEROL ESTER; LACTOSE 6 PHOSPHATE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MALONIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE P38; OXOGLUTARIC ACID; PEPTIDYLPROLYL ISOMERASE A; PURINE NUCLEOSIDE PHOSPHORYLASE; UNCLASSIFIED DRUG; YINXIELING;

ARTICLE; BLOOD STASIS SYNDROME; CHINESE MEDICINE; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DRUG MECHANISM; HEMATOLOGIC DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VIVO STUDY; LIPID METABOLISM; METABOLISM; METABOLOMICS; MOLECULAR DOCKING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TARGETING; PSORIASIS; URINALYSIS;

LATENT STRUCTURES DISCRIMINANT ANALYSIS; METABOLOMICS; PSORIASIS; SYNDROME DIFFERENTIATION; TRADITIONAL CHINESE MEDICINE;

ADOLESCENT; ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, CHINESE HERBAL; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; METABOLOMICS; MIDDLE AGED; MOLECULAR DOCKING SIMULATION; PROTEOMICS; PSORIASIS; SYSTEMS BIOLOGY;

EID: 84890129313     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2013.05.019     Document Type: Article

References (42)

1. S. Li, Z.Q. Zhang, L.J. Wu, X.G. Zhang, Y.D. Li, and Y.Y. Wang Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network IET Syst. Biol. 1 1 2007 51 60 (Pubitemid 46779218)
2. M. Jiang, C. Lu, C. Zhang, J. Yang, Y. Tan, A. Lu, and K. Chan Syndrome differentiation in modern research of traditional Chinese medicine J. Ethnopharmacol. 140 3 2012 634 642
3. A. Lu, M. Jiang, C. Zhang, and K. Chan An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis J. Ethnopharmacol. 141 2 2012 549 556
4. X. Wang, H. Sun, A. Zhang, W. Sun, P. Wang, and Z. Wang Potential role of metabolomics approaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine J. Pharm. Biomed. Anal. 55 5 2011 859 868
5. W. Xu, L. Zhang, Y. Huang, Q. Yang, H. Xiao, and D. Zhang Discrimination of type 2 diabetes mellitus corresponding to different traditional Chinese medicine syndromes based on plasma fatty acid profiles and chemometric methods J. Ethnopharmacol. 143 2 2012 463 468
6. J.K. Nicholson, J. Connelly, J.C. Lindon, and E. Holmes Metabonomics: a platform for studying drug toxicity and gene function Nat. Rev. Drug Discov. 1 2 2002 153 161 (Pubitemid 41646523)
7. N. Malandrino, and R.J. Smith Personalized medicine in diabetes Clin. Chem. 57 2 2011 231 240
8. L. Naldi Epidemiology of psoriasis Curr. Drug Targets Inflamm. Allergy 3 2 2004 121 128 (Pubitemid 38832741)
9. J.H. Zippin The genetics of psoriasis J. Drugs Dermatol. 2009 414 417
10. X.J. Zhang, W. Huang, and S. Yang Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21 Nat. Genet. 41 2009 205 210
11. L. Naldi, A. Svensson, and T. Diepgen Randomized clinical trials for psoriasis 1977-2000: the EDEN survey J. Invest. Dermatol. 120 2003 738 741 (Pubitemid 36529071)
12. S.N. Al-Suwaidan Feldman SR, Clearance is not a realistic expectation of psoriasis treatment J. Am. Acad. Dermatol. 42 2000 796 802 (Pubitemid 30252885)
13. B.X. Deng, C.Y. Jiang, P. Wang, W.L. Liu, X. Qu, and Y.M. Zhao Rule of distribution and development of TCM syndromes of psoriasis J. Tradit. Chin. Med. (Chin.) 47 10 2006 770 772
14. G.Z. Zhang, P. Wang, L.S. Wang, C.Y. Jiang, B.X. Deng, and P. Li Study on the distribution and development rules of TCM syndromes of 2651 psoriasis vulgaris cases J. Tradit. Chin. Med. (Chin.) 49 2008 894 896
15. T.H. Li, and X. Qu Study on the rule of distribution of TCM syndromes of psoriasis J. Tradit. Chin. Med. (Chin.) 51 2010 544 546
16. J. Gan, G.L. Xie, and Y. Shi Clinical observation of 48 psoriasis patients treated with combination of Chinese medicine and Western medicine J. Tradit. Chin. Med. Pharm. (Chin.) 14 7 2008 64
17. C.J. Lu, J.J. Yu, and J.W. Deng Disease-syndrome combination clinical study of psoriasis: present status, advantages, and prospects Chin. J. Integr. Med. 18 3 2012 166 171
18. Y. Yan, and Lu Chuanjian Optimized Yinxieling for treatment of psoriasis vulgaris, an exploratory clinical trial Tradit. Chin. Drug Res. Clin. Pharmacol. 22 6 2011 691 693
19. M.J. Gu, S.P. Gao, and Y.M. Li Effects of Yinxieling-optimization- decoction in treating psoriasis in mouse psoriasis models Zhong Xi Yi Jie He Xue Bao 7 6 2009 552 556
20. Psoriasis Group of Dermatology and Venereology, and Chinese Medical Association Clinical guidelines of psoriasis 2008 Chin. J. Dermatol. (Chin.) 42 2009 213 214
21. S. White, R. Vender, D. Thaçi, C. Haverkamp, J.M. Naeyaert, and R. Foster Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial Am. J. Clin. Dermatol. 7 2006 177 184 (Pubitemid 43845342)
22. S.M. Hewitt, J. Dear, and R.A. Star Discovery of protein biomarkers for renal diseases J. Am. Soc. Nephrol. 15 2004 677 1689
23. V. van der Meer Clinical research: case study on a patient with psoriasis Nat. Ther. 24 3 2008 26 29
24. K. Gyurcsovics, and L. Bertok Pathophysiology of psoriasis: coping endotoxins with bile acid therapy Pathophysiology 10 1 2003 57 61 (Pubitemid 37468512)
25. P. Bochsler, and D. Slauson Inflammation and repair of tissue D.O. Slauson, B. Cooper, Mechanisms of Disease, A Textbook of Comparative General Pathology 3rd ed. 2002 Mosby, Inc. St. Louis 140 245
26. R. Corrocher, S. Ferrari, and M. de Gironcoli Effect of fish oil supplementation on erythrocyte lipid pattern, malondialdehyde production and glutathione-peroxidase activity in psoriasis Clin. Chim. Acta 179 1989 121 131
27. 2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes J. Allergy Clin. Immunol. 114 6 2004 1403 1409 (Pubitemid 39575898)
28. M.R. Namazi Why is psoriasis uncommon in Africans? The influence of dietary factors on the expression of psoriasis Int. J. Dermatol. 43 5 2004 391 392 (Pubitemid 38714608)
29. W.R. Jr Henderson The role of leukotrienes in inflammation Ann. Intern. Med. 121 9 1994 684 697
30. H. Lithell, A. Bruce, and I.B. Gustafsson A fasting and vegetarian diet treatment trial on chronic inflammatory disorders Acta. Derm. Venereol. (Stockh.) 63 1983 397 403
31. S. Gerdes, and U. Mrowietz Comorbidities and psoriasis, impact on clinical practice Hautarzt 63 3 2012 202 213
32. B.H. May, A.L. Zhang, W. Zhou, C.J. Lu, S. Deng, and C.C. Xue Oral herbal medicines for psoriasis: a review of clinical studies Chin. J. Integr. Med. 18 3 2012 172 178
33. M. Chibowska Role of serum lipids in pseriasis Przegl. Epidemiol. 57 2 1970 255 260
34. M. Yamaoka-Tojo, T. Tojo, and R. Kosugi Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia Lipids Health Dis. 8 2009 41
35. M.J. Robinson, and M.H. Cobb Mitogen-activated protein kinase pathways Curr. Opin. Cell Biol. 9 1997 180 186 (Pubitemid 27135985)
36. R.J. Davis Transcriptional regulation by MAP kinases Mol. Reprod. Dev. 42 1995 459 467
37. C. Johansen, K. Kragballe, and M. Westergaard The mitogen-activated protein kinases p38 and ERK1 â2 are increased in lesional psoriatic skin Br. J. Dermatol. 152 2005 37 42
38. K. Sayama, M. Yamamoto, and Y. Shirakata E2 polyubiquitin-conjugating enzyme Ubc13 in keratinocytes is essential for epidermal integrity J. Biol. Chem. 285 2010 30042 30049
39. W. Chen, Z. Dong, and S. Valcic Inhibition of ultraviolet B-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line Mol. Carcinog. 24 1999 79 84 (Pubitemid 29115909)
40. Philip E. Morris Jr., and George A. Omura Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis Curr. Pharm. Des. 6 9 Jun. 2000 943 959 (Pubitemid 30409391)
41. D. Hijnen, E.F. Knol, Y.Y. Gent, B. Giovannone, and J P Beijn S CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22 J. Invest. Dermatol. 133 4 Apr. 2013 973 979
42. Iu.V. Tikhonov, L.I. Markusheva, and R.T. Toguzov Metabolism of purine compounds in psoriasis Klin. Lab. Diagn. 3 3 1998 3 6